Search

everythinglearnresearchcommunity

for

Search:↓

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

Following treatment plans is crucial to prevent worsening skin and hair conditions.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

The document concludes that Borrelia afzelii causes a skin condition in France, a gene is linked to hair loss in Caucasian women, and various genetic mutations affect skin diseases.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

The document suggests a possible connection between rapid weight loss and hair loss, and reports a case of skin condition improvement after stopping acne medication.

Cyclosporin doesn't stop hair loss.

Visible light can damage skin and most sunscreens don't block it well; more research is needed on its effects and protection methods.

Zinc deficiency in children can cause skin issues and can be serious if not diagnosed and treated properly.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Using psychological treatments can help manage skin conditions along with regular medical care.

Mice without the Sp6 gene have problems developing several body parts, including hair, teeth, limbs, and lungs.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Minoxidil in breast milk may harm nursing infants.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

Pediatric transplant patients often experience unique skin changes mainly due to medication use.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Good nutrition may help prevent premature hair graying.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Topical imiquimod is as effective as 5-fluorouracil for treating actinic keratosis, with about a 5% risk of it turning into squamous cell carcinoma.

Alopecia is a key indicator of thallium poisoning.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

Abrocitinib may effectively treat stubborn alopecia universalis.